T elomeres are nucleoprotein protective structures located at the termini of linear chromosomes. Telomeres comprise three nucleic acid species: double-stranded DNA (dsDNA) repeats (5′ -TTAGGG-3′ /5′ -CCCTAA-3′ in humans), ssDNA repeats resulting from protrusion of the 3′ G-rich strand over its complement (the G overhang), and the single-stranded G-rich long-noncoding RNA TERRA 1, 2 . Human TERRA is transcribed by RNA polymerase II from subtelomeric CpG-island promoters and contains stretches of the (UUAGGG) n sequence 3, 4 . After transcription, TERRA remains partly associated with telomeric chromatin and is thus in proximity to its DNA template 3, 5 .
The multiprotein complex shelterin supports chromosome integrity by preventing inappropriate DNA damage signaling and repair at telomeres 6, 7 . When shelterin is dysfunctional, chromosome ends are sensed as DNA double-stranded breaks (the endprotection problem) and become substrates for at least one of six DNA-damage-response pathways, ultimately leading to genome instability 6, 8 . Homodimers of the shelterin DNA-binding proteins TRF1 and TRF2 recognize double-stranded telomeric repeats and recruit the other shelterin components to telomeres 6, 7 . Although the N-terminal sequences of TRF1 (the acidic A domain) and TRF2 (the basic B domain) are largely divergent, the remaining homodimerization (TRFH), hinge, and Myb domains are structurally related 9 . TRF1 is thought to not directly participate in solving the end-protection problem, but rather to assist in semiconservative replication of telomeres, in part by recruiting helicases that resolve secondary structures formed by the G-rich strand 10, 11 . Consistently, TRF1 suppresses activation of the replication-stress-associated kinase ataxia telangiectasia and Rad3 related (ATR) and prevents formation of fragile telomeres (FTs), a signature of compromised DNA replication and, to a lesser extent, of telomere-free chromosome ends (TFEs) of unclear origin 10, 12 . TRF2 suppresses activation of the DNA-damage kinase ataxia telangiectasia mutated (ATM) and nonhomologousend-joining-mediated telomeric fusions 13 . TRF2 'caps' chromosome ends largely through its ability to stimulate intramolecular invasion of the G overhang into the duplex telomeric array, thereby forming protective lasso-like structures known as T loops 14, 15 .
Results
TRF2 stimulates TERRA invasion of double-stranded telomeric DNA in vitro. We rationalized that TERRA, like the G overhang, might invade double-stranded telomeric repeats. To investigate this possibility, we established an in vitro invasion assay in which a plasmid containing a telomeric DNA array (p-Tel) is incubated with radiolabeled single-stranded oligonucleotides and then electrophoresed in nondenaturing agarose gels 16 . Oligonucleotideinvaded plasmids are visualized as slowly migrating bands that are distinguishable from free single-stranded oligonucleotides ( Supplementary Fig. 1 ). RNA and DNA oligonucleotides comprising five G-or C-rich telomeric repeats readily invaded p-Tel in a sequence-specific manner, as random-sequence oligonucleotides did not invade p-Tel, and none of the oligonucleotides invaded a control empty plasmid ( Supplementary Fig. 1a,b ). Treatment of reaction products with recombinant RNase H, an endonuclease that degrades the RNA moiety of RNA-DNA duplexes, before electrophoresis strongly reduced the invaded plasmid signals ( Supplementary Fig. 1c ), demonstrating that RNA invasion led to R-loop formation.
We then carried out invasion assays with telomeric RNA and DNA oligonucleotides in the presence of glutathione S-transferase (GST)-tagged recombinant TRF proteins ( Supplementary Fig. 2a,b ). When incubated with radiolabeled oligonucleotides and resolved on denaturing polyacrylamide gels, none of the recombinant proteins affected the radiolabel signal ( Supplementary Fig. 2c ), thus ruling out the presence of contaminating nuclease or phosphatase activities. GST-TRF1, GST-TRF2 and GST alone did not alter invasion of C-rich RNA and DNA or of G-rich DNA at concentrations up to 80 nM ( Fig. 1 ). However, GST-TRF2, but not GST-TRF1, stimulated invasion of G-rich TERRA-like RNA ( Figs. 1 and 2a ) and R-loop formation ( Fig. 2a and Supplementary Fig. 1d ) in a concentrationdependent manner. Consistent with published data 16, 17 , GST-TRF2 stimulated G-rich-DNA invasion starting at a concentration of ~100 nM, at which maximum G-rich-RNA invasion was already achieved (Fig. 3a) , and high concentrations of GST-TRF1 had no effect on RNA or DNA invasion. A truncated variant of TRF2 lacking TRF1 participates in chromosome end protection by averting TRF2-dependent telomeric R loops the B domain (GST-TRF2Δ B) failed to promote RNA invasion at low concentrations ( Fig. 2a and Supplementary Fig. 2a,b ), whereas at high concentrations, it stimulated RNA and DNA invasion to similar extents, although with less efficiency than full-length GST-TRF2. A TRF2 variant lacking the C-terminal dsDNA-binding Myb domain 18 (GST-TRF2Δ M) and another variant that is unable to induce topological changes in telomeric DNA (GST-Topless) 17 did not stimulate RNA or DNA invasion at any concentration ( Fig. 2a , Supplementary Fig. 2a ,b, and data not shown). Finally, heat-denatured GST-TRF2 also failed to induce RNA invasion ( Fig. 2a ).
As expected, in electrophoretic mobility shift assays (EMSAs), GST-TRF2Δ M did not bind to telomeric dsDNA substrates, whereas GST-Topless bound similarly to GST-TRF2 ( Supplementary Fig.  2d and Supplementary Table 1 ). GST-TRF2Δ B bound dsDNA approximately four-fold less efficiently than did GST-TRF2 ( Supplementary Fig. 2d ,e and Supplementary Table 1 ), which is not sufficient to explain the observed inefficiency of GST-TRF2Δ B in stimulating RNA invasion. Indeed, whereas GST-TRF2 promoted maximum RNA invasion at a concentration of ~40 nM (Figs. 1 and 2a), GST-TRF2Δ B only induced an ~1.5-fold increase in RNA invasion at ~400 nM ( Fig. 3a ). We conclude that TRF2 stimulates G-rich-RNA invasion with higher efficiencies than it does with G-rich DNA. This novel TRF2-associated activity requires TRF2 binding to and wrapping of double-stranded telomeric DNA, as is also the case for G-rich-DNA invasion 16, 17 , and is specifically potentiated by the TRF2 B domain. Reinforcing the importance of the B domain for efficient RNA invasion, a chimeric protein in which the A domain of TRF1 was swapped with the B domain of TRF2 (GST-BTRF1Δ A) readily induced RNA invasion (Supplementary Figs. 2a,b and 3a), despite binding to telomeric dsDNA ~18fold less efficiently than GST-TRF2 (Supplementary Fig. 2e and Supplementary Table 1 ). TRF1 A domain suppresses TERRA invasion of double-stranded telomeric DNA. When G-rich-RNA invasion reactions were performed with fixed amounts of GST-TRF2 and increasing amounts of GST-TRF1, we observed a progressive decline in invaded plasmid species ( Fig. 2b) . In contrast, GST-TRF1 did not inhibit the G-rich-DNA invasion stimulated by high concentrations of GST-TRF2 ( Fig. 3b) . A truncated TRF1 variant lacking the A domain (GST-TRF1Δ A) failed to neutralize GST-TRF2-stimulated RNA invasion at any tested concentration (Figs. 2b and 3b and Supplementary Fig. 2 ). As with GST-TRF1, GST-TRF1Δ A did not promote RNA invasion or prevent GST-TRF2 from inducing DNA invasion at high concentrations ( Fig. 3b and Supplementary Fig. 3 ). Because the Myb domains of TRF1 and TRF2 bind the same dsDNA substrate 18 , we considered the possibility that GST-TRF1 counteracted GST-TRF2 by reducing its density on DNA and that GST-TRF1Δ A simply binds dsDNA much less efficiently than its full-length counterpart. However, GST-TRF1Δ A bound to telomeric dsDNA substrates only ~1.1-1.5fold less efficiently than GST-TRF1 (Supplementary Table 1 ). These minor differences are unlikely to explain why GST-TRF1Δ A did not suppress TRF2-mediated RNA invasion, as the concentration ranges examined for TRF1 proteins covered a wide range from 0 to 400 nM.
Additional evidence argues against the hypothesis that GST-TRF1 suppresses GST-TRF2-mediated RNA invasion through (UUAGGG) 5 (TTAGGG) 5 (CCCUAA) 5 (CCCTAA dsDNA substrate competition. First, in dsDNA EMSAs with increasing amounts of GST-TRF1 or GST-TRF1Δ A in the presence or absence of GST-TRF2, bound probes further shifted toward the wells when GST-TRF2 was included ( Supplementary  Fig. 3b ), indicating that GST-TRF1/TRF1Δ A and GST-TRF2 concomitantly bind the same substrate under our experimental conditions. Second, western blot analysis of strand-invasion products revealed no change in the amount of dsDNA-bound GST-TRF2 when GST-TRF1 or GST-TRF1Δ A was included in the reactions ( Supplementary Fig. 3c ). We also considered the possibility that the inability of GST-TRF1Δ A to inhibit TRF2-stimulated RNA invasion reflected the ability of GST-TRF1Δ A, but not of GST-TRF1, to bind and thus stabilize telomeric RNA-DNA hybrids. However, none of the recombinant TRF proteins used in this study bound telomeric RNA-DNA hybrid substrates, in contrast to a GST-fused hybridbinding domain of human RNase H1 (ref. 19 ) (Supplementary Figs. 2a,b and 3d). We conclude that TRF1 inhibits TRF2-stimulated invasion of TERRA, but not of G-rich ssDNA, and this inhibitory activity requires the A domain.
TRF1 A domain suppresses TRF2 B domain binding to TERRA.
To shed some light on the mechanisms by which the A domain suppresses TRF2-stimulated RNA invasion, we set up RNA EMSAs. In agreement with previously published data 20 , we found that GST-TRF2, GST-TRF2Δ B, GST-TRF1 and GST-TRF1Δ A bound to G-rich telomeric RNA oligonucleotides but not to C-rich or randomsequence RNA oligonucleotides or to telomeric or random-sequence DNA oligonucleotides ( Fig. 4 and Supplementary Fig. 3e ). TRF2Δ B bound G-rich RNA less efficiently than did GST-TRF2, whereas binding kinetics of GST-TRF1 and GST-TRF1Δ A were indistinguishable ( Fig. 4a,b and Supplementary Table 1 ). Consistently, GST fused to the B domain (GST-B) bound G-rich RNA, whereas GST fused to the A domain (GST-A) did not ( Fig. 4a ,b, Supplementary  Fig. 2 and Supplementary Table 1 ). Fusing the A domain to the N terminus of the B domain (GST-AB) largely abolished RNA binding, whereas fusing the A domain to the N terminus of TRF2 (GST-ATRF2) decreased binding to levels comparable to that of GST-TRF2Δ B. As expected, GST-A, GST-B and GST-AB did not bind telomeric dsDNA ( Supplementary Fig. 2f ).
Based on these results, we propose that the direct binding of G-rich RNA to the B domain drives highly efficient TRF2-stimulated RNA invasion and that the A domain of TRF1 counteracts this mechanism, probably by impeding interaction of the B domain with G-rich RNA. Consistent with this hypothesis, low concentrations of GST-ATRF2 failed to promote efficient RNA invasion, although its ability to bind to telomeric dsDNA was not compromised ( Fig. 4c , Supplementary Fig. 2d and Supplementary Table 1 ). Similarly to GST-TRF2Δ B, GST-ATRF2 mildly stimulated RNA and DNA invasion at high protein concentrations ( Fig. 3a ).
TRF1 A domain suppresses telR loops in cells.
Our in vitro data suggest that TRF1 and TRF2 'cross-talk' regulates TERRA interaction with telomeric dsDNA in cells. We depleted TRF1 using short interference RNAs (siRNAs) both in telomerase-positive HeLa and in alternative lengthening of telomeres (ALT) 21 U2OS cancer cells and quantified telR loops by immunoprecipitation with the RNA-DNA-hybrid-specific S9.6 antibody (S9.6 DRIPs), followed by dotblot hybridization 22, 23 . In both cell lines, TRF1 depletion increased telR loops but not R loops containing Alu-repeat sequences ( Fig. 5a and Supplementary Figs. 4 and 5). Ectopic expression of an siRNAinsensitive flag-tagged TRF1 (fl-TRF1) in TRF1-depleted HeLa cells prevented telR-loop accumulation, whereas its A-deleted counterpart (fl-Δ A) did not ( Fig. 5b and Supplementary Fig. 4 ). In fact, these assays revealed that fl-Δ A expression alone increased telR loops, suggesting a dominant-negative effect, probably caused by replacement of endogenous TRF1 at telomeres ( Supplementary Fig. 6a -c).
Notably, combining TRF1 depletion with fl-Δ A expression did not significantly increase telR loops above levels seen in TRF1-depletion conditions ( Fig. 5b ), indicating impairment of the same TRF1associated function involved in suppressing telR loops. The TRF1 A domain recruits the poly(ADP-ribose) polymerase Tankyrase 1 (TNK1) to telomeres 24 . We depleted TNK1 in HeLa and U2OS cells using siRNA and observed the expected accumulation of mitotic cells 25 ( Supplementary Fig. 7a,b ). However, TNK1 depletion did not alter telR-loop levels ( Supplementary Fig. 7c ), thereby eliminating the possibility that the increased telR loops observed in cells depleted of TRF1 or expressing fl-Δ A are due to insufficient TNK1 at telomeres.
TRF1 A domain suppresses R-loop-dependent telomere instability.
In ALT cells, aberrant accumulation of telR loops leads to telomere-dysfunction-induced foci (TIFs) that contain telomeric DNA and a Ser33-phosphorylated form of the ssDNA-binding protein RPA32 (pSer33) and to metaphase TFEs 22 . pSer33 also accumulates at R loops throughout the genome 26 . TRF1 depletion and fl-Δ A expression increased pSer33 TIFs and TFEs both in HeLa Supplementary Fig. 4c,d ) and in U2OS cells (Fig. 7a,b and Supplementary Fig. 5d ). TFEs were detected at chromosome ends generated by both lagging-and leading-strand replication Supplementary Fig. 4c,d ). As expected 10 , FTs also accumulated in TRF1-depleted cells (Figs. 6a,b and 7a and Supplementary Fig. 4d ); both fl-TRF1 and fl-Δ A averted the increase in FTs in the same cells (Fig. 6a,b and Supplementary  Fig. 4d ) and suppressed spontaneous FTs in cells in which endogenous TRF1 was not depleted (Figs. 6b and 7b). Ectopic expression of a myc-tagged version of the human RNase H1 endoRNase (RH1 wt ) prevented the accumulation of telR loops, pSer33 TIFs and TFEs upon TRF1 depletion or fl-Δ A expression, whereas a catalytically dead RNase H1 (RH1 CD ) 19 did not (Figs. 5b,d  and 6b and Supplementary Fig. 4a,b ,e-l). FTs accumulated at similar frequencies in TRF1-depleted cells expressing either RH1 wt or RH1 CD (Fig. 6b) . These data establish that suppression of pSer33 TIFs and TFEs through restriction of telR loops are previously unappreciated TRF1 functions that strictly depend on the A domain and are genetically separable from fragility suppression.
TelR loops suppressed by the TRF1 A domain depend on TRF2.
Our biochemical data suggest that the TRF1 A domain suppresses telR loops induced by TRF2-stimulated TERRA invasion. To test this hypothesis in cells, we first overexpressed N-terminally myctagged TRF2 (m-TRF2) and ATRF2 (m-ATRF2) in HeLa cells and found that m-TRF2 but not m-ATRF2 increased telR-loop and pSer33TIF levels ( Fig. 8a-e ). This finding may explain the stochastic telomere loss and consequent TFE appearance previously observed in human and mouse cells overexpressing TRF2 (refs. 27, 28 ). Furthermore, depleting endogenous TRF2 prevented the accumulation of telR loops in TRF1-depleted and fl-Δ A-expressing cells ( Supplementary Fig. 8a-d) . Consistent with the notion that uncontrolled TRF2-dependent telR loops cause telomere instability, TRF2 depletion averted the insurgence of pSer33 TIFs and TFEs in fl-Δ A-expressing cells ( Fig. 5d and Supplementary  Fig. 8e,f) . As expected, TRF2 depletion did not affect FT frequencies ( Supplementary Fig. 8f ).
Discussion
We have identified two novel, interdependent activities of TRF proteins at human telomeres: (i) TRF2 promotes TERRA invasion into telomeric dsDNA, probably through direct interactions of the B domain with TERRA, possibly recruiting it to telomeres and through the TRFH domain's ability to wrap telomeric dsDNA and alter its topology; (ii) TRF1, through its A domain, maintains constant control of the TERRA-invasion activity mediated by TRF2 (Fig. 8f) . The molecular basis of TRF1's ability to discriminate RNA from DNA during TRF2-mediated strand invasion remains to be determined. Still, because the TRF2 B domain is only able to interact with TERRA and not with telomeric ssDNA, template discrimination may derive from the ability of the TRF1 A domain to prevent TERRA from interacting with the TRF2 B domain. We have also shown that in the absence of controlled cross-talk between these novel activities (a situation recapitulated by TRF1 depletion or TRF1Δ A expression in cells), aberrant telR loops accumulate and lead to the generation of pSer33 TIFs and telomere loss (Fig. 8f ). We therefore propose that uncontrolled TRF2 and telR loops pose authentic threats to telomere integrity and that TRF1 directly contributes to solving the end-protection problem by suppressing unscheduled telR-loop-induced telomere instability.
Our data unambiguously demonstrate the harmful potential of TRF2-dependent telR loops, raising the question of the evolutionary and functional advantage of this unexpected TRF2 activity. One possibility is that TERRA invasion is a secondary, unwanted reaction associated with TRF2-mediated stimulation of T-loop formation. In this light, the A domain might have evolved to specifically prevent telR-loop formation without interfering with T-loop establishment. However, disfavoring this simple hypothesis, our in vitro data suggest that TRF2 stimulates TERRA invasion with higher efficiency than G-overhang invasion. It is possible that programmed TRF2-mediated RNA invasion, promoted by regulated TRF1 removal from telomeres 29 for example, may serve specific functions in particular cellular settings, such as during replicative senescence, telomerase recruitment and telomere recombination 22, [29] [30] [31] . Moreover, the TRF2 B domain was shown to bind to three-and four-way Holliday junctions irrespective of their sequences, and such activity was recently proved essential in preventing T-loop cleavage and telomere excision [32] [33] [34] . It will be important to determine to what extent the functions of the B domain in promoting TERRA invasion and repressing T-loop cleavage are interconnected. Lastly, RNA-invasion activities like that of TRF2 could be involved in the formation of intrachromosomal, post-transcriptional R loops comprising messenger or noncoding RNAs of nontelomeric origin. Because genome-wide-spread R loops are well-established triggers of chromosome instabilities that are frequently observed in cancer cells 35 , the identification of such activities could help extend our understanding of cancer etiology.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41594-017-0021-5.
Plasmids. TRF1 and TRF2 cDNAs were derived from the pLPC-NFLAGTRF1 and pLPC-NMYCTRF2 retroviral vectors (kind gifts from T. de Lange (The Rockefeller University, New York)). TOPLESS cDNA was a kind gift from E. Gilson (IRCAN, Nice, France). All successive manipulations were performed by PCR and validated by sequencing. For expression in mammalian cells, we deleted the A-domain sequence from the pLPC-NFLAGTRF1 plasmid or cloned both NFLAGTRF1 and NFLAGTRF1Δ A cDNAs into the lentiviral vector pLVX-TetOne-Puro (Clontech). NMYCTRF2 and NMYCATRF2 cDNAs were cloned into the pLVX-TetOne-Puro vector. Full-length human RNASEH1 cDNA was purchased from Origene, fused in frame with a C-terminal Myc tag and cloned into the retroviral vector pLHCX (Clontech). Catalytically dead RNASEH1 was obtained by changing the aspartic acid at position 145 into alanine (D145A) 19 using the Q5 site-directed mutagenesis kit (New England Biolabs). For expression in bacteria cells, cDNAs for different TRF proteins were N-terminally fused in frame to a GST sequence by cloning into the pGEX-4T1 vector (GE Healthcare). The RNA-DNA-hybrid-binding domain of RNase H1 was PCR amplified from the pLHCX-MYCRNASEH1 plasmid and cloned into the pGEX-4T1 vector. The p-Tel plasmid was generated by cloning a stretch of ~800 bp of telomeric DNA (kind gift from E. Gilson) into pcDNA6 (Life Technologies). Western blotting. Total proteins prepared in 2× Laemmli buffer were separated in 8-10% polyacrylamide gels and transferred to nitrocellulose membranes (Maine Manufacturing, LLC) using a Trans-Blot SD Semi-Dry Transfer Cell apparatus (Bio-Rad). Western blots were performed according to standard procedures using the following primary antibodies: a mouse monoclonal anti-TRF2 (Millipore, 05-521, dilution 1:2,000), a rabbit polyclonal anti-TRF1 raised against full-length recombinant TRF1 (kind gift from J. Karlseder (The Salk Institute for Biological Studies, La Jolla, CA, USA), 1:2,000), a rabbit polyclonal anti-Tankyrase 1 (kind gift from S. Smith (The Skirball Institute of Biomolecular Medicine, New York), 1:5,000), a rabbit polyclonal anti-RNaseH1 (GeneTex, GTX117624, 1:1,000), a mouse monoclonal anti-hbetaActin (Abcam, ab8224, 1:10,000) and a rabbit polyclonal anti-LaminA (GeneTex, GTX111677S, 1:5,000). Secondary antibodies were HRP-conjugated goat anti-mouse and anti-rabbit IgGs (Bethyl Laboratories, 1:5,000). Signals were acquired using a FluorChem HD2 apparatus (Alpha Innotech).
DNA FISH and CO-FISH.
Metaphase DNA FISH was performed as previously described 3 . Briefly, cells were treated with 200 ng/ml Colcemid (Sigma-Aldrich) for 2-3 h, harvested and incubated in 0.075 M KCl for 9 min at 37 °C. Chromosomes were fixed in cold methanol/acetic acid (3:1), spread on glass slides and treated with 20 μ g/ml DNase-free RNase A (Sigma-Aldrich), 1× PBS for 1 h at 37 °C. Hybridizations were performed in 30% formamide, 2× SSC for 3 h at room temperature with a TexasRed-labeled LNA probe (5′ -Tex615-GGGT*TAGGG *T*TAG*GGTTAGGG*T*TAGGG*T*TAGGG*TTA-3′ ; asterisks (*) indicate LNA nucleotides; Exiqon). Post-hybridization washes were in 2× SSC at room temperature. DNA was counterstained with DAPI (Sigma-Aldrich). Metaphase CO-FISH was performed as previously described 8 with some modifications. Cells were incubated with BrdU/BrdC (3:1, final concentration 10 μ M) for 16 h before metaphase preparation as described above. Chromosomes were spread on glass slides, treated with DNase-free RNase A as described above and incubated with 10 μ g/ml Hoechst 33258 (Invitrogen) in 2× SSC for 15 min at room temperature. Slides were then exposed to 365-nm UV light using a Stratagene Stratalinker 1800 UV irradiator set to 5,400 Joules and incubated with 3U/μ l Exonuclease III (New England Biolabs) for 30 min at 37 °C. Hybridizations were performed in 30% formamide, 2× SSC for 3 h at room temperature using 6-FAM-or TYE563-labeled LNA probes (TelC LNA probe: 5′ -6-FAM-CCC*TAACCC*TAACCC*TAA-3′ ; TelG LNA probe: 5′ -TYE563-T*TAGGGT*TAGGGT*TAGGG; asterisks (*) indicate LNA nucleotides; Exiqon). Post-hybridization washes were in 2× SSC at room temperature. DNA was counterstained with DAPI (Sigma-Aldrich). Images were acquired with an Olympus IX 81 microscope equipped with a Hamamatsu ORCA-ER camera using a 60× 1.42NA oil PlanAPoN objective or with a Deltavision Multiplexed system (Applied Precision) with an Olympus 1× 71 (inverse) microscope, Roper CoolSnap HQ2 camera and a 60× 1.4NA oil DIC PlanAPoN objective. Images were analyzed using ImageJ and Adobe Photoshop. Statistical analysis was performed in Prism (GraphPad) with a Mann-Whitney U test as indicated in figure legends. The number of independent experiments (n) is also indicated in figure legends.
Indirect immunofluorescence. Cells grown on coverslips were washed with icecold 1× PBS, and soluble cellular material was extracted with CSK buffer (100 mM NaCl, 300 mM sucrose, 3 mM MgCl 2 , 0.5% Triton X-100, 10 mM PIPES, pH 6.8) for 7 min on ice. Cells were fixed in 3.7% formaldehyde for 10 min, washed in 1× PBS and permeabilized again with CSK buffer for 5 min at room temperature. Cells were blocked in 5 mg/ml BSA, 0.05% Tween-20 in 1× PBS and then incubated with primary antibodies diluted in blocking solution for 1 h at room temperature. Antibodies were as follows: a mouse monoclonal anti-Flag (Sigma-Aldrich, F1804, 1:1,000), a mouse monoclonal anti-Myc (Sigma-Aldrich M4439, 1:500), a rabbit polyclonal anti-pSer33, (Bethyl Laboratories A300-244A, 1:500), a mouse monoclonal anti-TRF2 (Millipore, 05-521, 1:500) and a mouse monoclonal mix raised against a recombinant peptide spanning the A domain of hTRF1 (raised at the monoclonal antibody facility of Max F. Perutz Laboratories in Vienna, 1:100). Secondary antibodies were donkey anti-rabbit and donkey anti-mouse IgGs conjugated with Alexa Fluor 568 or Alexa Fluor 488 (Invitrogen, 1:5,000). For IF/ DNA FISH, immunostained cells were fixed with 3.7% formaldehyde for 10 min at room temperature and hybridized as for metaphase DNA FISH. Images were acquired with an Olympus IX 81 microscope equipped with a Hamamatsu ORCA-ER camera using a 60× 1.42NA oil PlanAPoN objective or the Zeiss Cell Observer equipped with a cooled Axiocam 506 m camera and using a 63× /1.4NA oil DIC M27 PlanApo objective. 20 z sections of 0.5 μ m were taken, and colocalization analysis was performed using ImageJ on separate sections. A total of 100 nuclei were analyzed for each sample in each independent experiment. Statistical analysis was performed in Microsoft Excel using a two-tailed Student's t test as indicated in figure legends. The number of independent experiments (n) is also indicated in figure legends.
GST protein purification. The pGEX-4T1 plasmids were transformed into competent BL21 cells. Cells were grown in LB media until they reached an O.D of 0.4 (600 nm), and protein expression was induced with 50 μ M IPTG (Sigma-Aldrich) for 5 h at 25 °C. Cells were collected by centrifugation and lysed by sonication in 25 ml of GST pulldown buffer (50 mM potassium phosphate buffer, pH 7, 5 mM EDTA, 100 mM NaCl, 1% Triton X-100, 0.15 mM PMSF). Lysates were incubated with Glutathione Sepharose 4B beads (GE Healthcare) in GST pulldown buffer for 5 h at 4 °C on a rotating wheel. Beads were washed with 10 ml of GST pulldown buffer three times, and bound proteins were eluted in 200 μ l of GST elution buffer (50 mM potassium phosphate buffer, pH 7, 5 mM EDTA, 100 mM NaCl, 5% glycerol, 25 mM glutathione) for 15 min at 4 °C. Protein concentration and purity were determined using the Bradford protein assay (Bio-Rad) and BSA reference samples, followed by fractionation of equal amounts of proteins in polyacrylamide gels and staining with the EZBlue reagent (Sigma-Aldrich). Note that all protein concentrations refer to TRF monomers. Proteins were stored at -20 °C for up to one month.
Strand-invasion assays. Strand-invasion assays were performed adapting previously described protocols 16, 36 . pcDNA6 and p-Tel plasmids were purified using the GeneJET plasmid miniprep Kit (Thermo Fisher Scientific) and repurified twice using the DNA Clean & Concentrator Kit (Zymo Research) to assure removal of RNase contaminations. DNA and RNA oligonucleotides were synthesized and PAGE purified at Microsynth. Sequences were as follows: 5′ -(TTAGGG) 5 -3′ , 5′ -(UUAGGG) 5 -3′ , 5′ -(CCCTAA) 5 -3′ , 5′ -(CCCUAA) 5 Biolabs) were added to the reactions followed by an incubation of 15 min at 37 °C. Reactions were stopped by adding 4 μ l of 6× gel-loading buffer (30% glycerol, 0.3% bromophenol blue, 0.3% xylene cyanol) containing 12% SDS and incubating for 5 min at room temperature. Reaction products were fractionated by electrophoresis in 1% agarose gels. Gels were dried and exposed to a phosphorimager screen. Radioactive signals were detected using a Typhoon FLA 9000 imager (GE Healthcare) and quantified using ImageJ. Statistical analysis was performed in Microsoft Excel using a two-tailed Student's t test as indicated in figure legends. The number of independent experiments (n) is also indicated in figure legends.
Western blotting strand-invasion assays. Reactions were performed exactly as for invasion assays using 50 ng of pTel plasmid (0.6 nM final concentration), the indicated amounts of recombinant proteins and 10 nM 5′ -(UUAGGG) 5 5 substrate was generated by annealing 5′ -end radiolabeled 5′ -(UUAGGG) 5 -3′ oligonucleotides with a two-fold molar excess of unlabeled 5′ -(CCCTAA) 5 -3′ oligonucleotides. Recombinant proteins and nucleic acids were incubated in 20 μ l of strand-invasion buffer containing 50 ng/μ l Escherichia coli tRNAs (Sigma-Aldrich) and 10 U of RNaseOUT (Thermo Fisher Scientific) for 20 min at 24 °C. 4 μ l of 6× gel-loading buffer was added to the reactions, which were then electrophoresed in 2% agarose gels. Gels were dried and exposed to a phosphorimager screen. Radioactive signal detection and analysis were the same as those for invasion assays. The number of independent experiments (n) is indicated in figure legends. Corresponding author(s): Claus M. Azzalin
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